Big pharma seeks regulatory changes as R&D spending continues downward spiral
R&D spending in Canada by patent-holding pharmaceutical firms declined 2.9% in 2009 — the largest single annual drop in the past 22 years — amidst escalating calls by industry for a more globally competitive regulatory and operating environment.
Other stories mentioning these organizations, people and topics
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 0 free articles remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.